Strategy Asset Managers’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-210,973	Closed	-$7.01M	–	145
2017 Q2	$7.01M	Buy	210,973 +29,526	+16%	+$914K	1.44%	26
2017 Q1	$5.82M	Buy	181,447 +7,269	+4%	+$248K	1.26%	29
2016 Q4	$6.01M	Buy	174,178 +17,035	+11%	+$680K	1.32%	29
2016 Q3	$7.23M	Buy	157,143 +112	+0.1%	+$5.84K	1.62%	26
2016 Q2	$7.89M	Buy	157,031 +1,686	+1%	+$89.8K	1.79%	24
2016 Q1	$8.31M	Sell	155,345 -9,197	-6%	-$540K	1.89%	21
2015 Q4	$10.8M	Sell	164,542 -4,702	-3%	-$291K	2.46%	9
2015 Q3	$9.56M	Sell	169,244 -3,061	-2%	-$198K	2.29%	13
2015 Q2	$10.2M	Sell	172,305 -3,922	-2%	-$242K	2.27%	14
2015 Q1	$11M	Sell	176,227 -9,287	-5%	-$540K	2.4%	8
2014 Q4	$10.7M	Sell	185,514 -2,877	-2%	-$160K	2.24%	13
2014 Q3	$10.1M	Buy	188,391 +227	+0.1%	+$12K	2.21%	15
2014 Q2	$9.86M	Sell	188,164 -2,347	-1%	-$120K	2.1%	19
2014 Q1	$10.1M	Buy	190,511 +3,585	+2%	+$166K	2.17%	16
2013 Q4	$7.49M	Buy	186,926 +4,586	+3%	+$181K	1.64%	26
2013 Q3	$6.89M	Buy	182,340 +2,401	+1%	+$93.7K	1.63%	26
2013 Q2	$7.05M	Buy	+179,939	New	+$7.01M	1.68%	25